Aceto Moves Ahead With Rising Divestment

Aceto has received approval to divest its Rising Pharmaceuticals unit to Shore Suven Pharma for $15m as part of bankruptcy proceedings.

Handshake
Aceto’s Deal To Sell Rising Has Received Court Approval • Source: Shutterstock

Aceto’s sale of Rising Pharmaceuticals can go ahead, the US Bankruptcy Court has decided, approving a ‘stalking horse’ deal recently concluded between Aceto and Shore Suven Pharma.

Under the terms of the deal, Aceto will sell its Rising Pharmaceuticals unit and related businesses to Shore Suven Pharma...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business